Circulating tumor cell analysis from the cerebrospinal fluid informs early diagnosis, treatment and prognosis in leptomeningeal carcinomatosis (LMC) SNO/ASCO CNS Cancer Conference 2023BioceptAugust 14, 2023
The HER2 Flip: HER2 Amplification of Tumor Cells in the Cerebrospinal Fluid (CSF-TCs) of Patients with Leptomeningeal Metastasis having solid tumors; implications for treating the LM tumor with anti-HER2 therapy SNO/ASCO CNS Cancer Conference 2023BioceptAugust 14, 2023
Evaluating the diagnostic performance of leptomeningeal diagnosis with CNSide compared to standard cytology. American Society of Clinical Oncology 2023BioceptJune 5, 2023
The HER2 Flip: HER2 Amplification of Tumor Cells in the Cerebrospinal Fluid (CSF-TCs) of Patients with Leptomeningeal Metastasis Having Solid Tumors; Implications for Treating the LM Tumor with Anti_HER2 Therapy Society for Neuro-Oncology 2022BioceptNovember 22, 2022
The Detection of Disseminated Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID) in Cerebrospinal Fluid (CSF) Using Cell Capture and Immunocytochemistry Society for Neuro-Oncology 2022BioceptNovember 22, 2022
Detection of Mutant p53 Positive Glioblastoma Cells in Cerebrospinal Fluid (CSF) Using a Microfluidic Based Immunoassay Society for Neuro-Oncology 2022BioceptNovember 22, 2022
Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay Clinical Breast Cancer 2022BioceptAugust 26, 2022
Using Cerebrospinal Fluid Tumor Cell (CSF-TC) Assays to Track Disease Burden and Treatment Response in Patients with Leptomeningeal Metastasis American Academy of Neurology 2022BioceptApril 7, 2022
Characterization of HER2 Amplification in the Cerebrospinal Fluid of Patients with Leptomeningeal Disease in Stage IV Patients with Breast Cancer San Antonio Breast Cancer Symposium 2021BioceptDecember 8, 2021
Case Series of Multi-Institutional Utility of CNSide™ to Manage Leptomeningeal Disease in Patients with Metastatic Breast Cancer Society for Neuro-Oncology 2021BioceptNovember 25, 2021